ago-ovar 2.29/engot-ov34: atezolizumab vs placebo bevacizumab w/ chemo recurrent ovarian cancer
Published 3 months ago • 71 plays • Length 6:10Download video MP4
Download video MP3
Similar videos
-
6:36
atezolizumab versus placebo in combination with bevacizumab and non-platinum-based chemotherapy ...
-
1:31
ctdna and hrd analysis of a phase ii trial of atezolizumab combo in recurrent ovarian cancer
-
2:07
recurrent and metastatic ovarian cancer treatment
-
0:42
dr. zsiros discusses pembrolizumab triplet in recurrent ovarian cancer
-
6:04
when to add bevacizumab for recurrent ovarian cancer
-
1:17:45
recurrent ovarian cancer (2023)
-
58:21
recurrent ovarian cancer - questions and answers (2022)
-
55:45
treatment advances in ovarian cancer recurrence
-
7:32
bevacizumab for recurrent ovarian cancer
-
30:19
emerging opportunities in platinum-resistant recurrent ovarian cancer
-
7:46
all about treatment for recurrent ovarian cancer
-
4:54
bevacizumab in recurrent ovarian cancer
-
3:11
ovarian cancer phase iii trial updates: imagyn050 and icon8
-
9:08
factors in choice of treatment for recurrent ovarian cancer
-
0:48
lowering risk of ovarian cancer recurrence
-
59:44
what clinical trials are recruiting for recurrent ovarian cancer?
-
23:15
is it time to change upfront chemotherapy for ovarian cancer?
-
1:01
'maintenance treatment' could delay or prevent ovarian cancer recurrence
-
6:34
bevacizumab’s value in recurrent ovarian cancer
-
5:41
bevacizumab’s role in recurrent ovarian cancer
-
1:30
dr. mirza on the evolving treatment landscape in recurrent ovarian cancer
-
2:50
aurelia: phase 3 trial of bevacizumab combined with chemotherapy for ovarian cancer